vs
Side-by-side financial comparison of DUOS TECHNOLOGIES GROUP, INC. (DUOT) and Taysha Gene Therapies, Inc. (TSHA). Click either name above to swap in a different company.
DUOS TECHNOLOGIES GROUP, INC. is the larger business by last-quarter revenue ($9.5M vs $5.5M, roughly 1.7× Taysha Gene Therapies, Inc.). DUOS TECHNOLOGIES GROUP, INC. runs the higher net margin — -33.8% vs -507.8%, a 474.0% gap on every dollar of revenue. On growth, DUOS TECHNOLOGIES GROUP, INC. posted the faster year-over-year revenue change (547.5% vs 171.3%). Over the past eight quarters, DUOS TECHNOLOGIES GROUP, INC.'s revenue compounded faster (149.0% CAGR vs 26.8%).
DUOS Technologies Group Inc. develops and deploys AI-powered automation, inspection, and security solutions for railway transportation, critical infrastructure, and commercial clients across North America. Its offerings include real-time monitoring systems and safety tools that help customers boost efficiency, reduce risks, and strengthen site security.
Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company specializing in developing adeno-associated virus (AAV)-based gene therapies for rare monogenic central nervous system disorders with high unmet medical needs. Its core pipeline targets serious life-threatening neurological conditions, with primary operations and market focus across North America and European regions.
DUOT vs TSHA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $9.5M | $5.5M |
| Net Profit | $-3.2M | $-27.9M |
| Gross Margin | 26.7% | — |
| Operating Margin | -36.1% | -516.0% |
| Net Margin | -33.8% | -507.8% |
| Revenue YoY | 547.5% | 171.3% |
| Net Profit YoY | 6.1% | -48.3% |
| EPS (diluted) | $-0.10 | $-0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.5M | $5.5M | ||
| Q3 25 | $6.9M | $0 | ||
| Q2 25 | $5.7M | $2.0M | ||
| Q1 25 | $5.0M | $2.3M | ||
| Q4 24 | $1.5M | $2.0M | ||
| Q3 24 | $3.2M | $1.8M | ||
| Q2 24 | $1.5M | $1.1M | ||
| Q1 24 | — | $3.4M |
| Q4 25 | $-3.2M | $-27.9M | ||
| Q3 25 | $-1.0M | $-32.7M | ||
| Q2 25 | $-3.5M | $-26.9M | ||
| Q1 25 | $-2.1M | $-21.5M | ||
| Q4 24 | $-3.4M | $-18.8M | ||
| Q3 24 | $-1.4M | $-25.5M | ||
| Q2 24 | $-3.2M | $-20.9M | ||
| Q1 24 | — | $-24.1M |
| Q4 25 | 26.7% | — | ||
| Q3 25 | 36.6% | — | ||
| Q2 25 | 26.5% | — | ||
| Q1 25 | 26.5% | — | ||
| Q4 24 | -22.6% | — | ||
| Q3 24 | 28.4% | — | ||
| Q2 24 | -14.2% | — | ||
| Q1 24 | — | — |
| Q4 25 | -36.1% | -516.0% | ||
| Q3 25 | -16.2% | — | ||
| Q2 25 | -60.0% | -1347.1% | ||
| Q1 25 | -36.1% | -930.5% | ||
| Q4 24 | -211.2% | -985.8% | ||
| Q3 24 | -59.3% | -1448.4% | ||
| Q2 24 | -212.9% | -1915.4% | ||
| Q1 24 | — | -713.3% |
| Q4 25 | -33.8% | -507.8% | ||
| Q3 25 | -15.1% | — | ||
| Q2 25 | -61.3% | -1353.6% | ||
| Q1 25 | -42.0% | -935.2% | ||
| Q4 24 | -233.2% | -929.0% | ||
| Q3 24 | -43.3% | -1427.5% | ||
| Q2 24 | -212.1% | -1882.0% | ||
| Q1 24 | — | -705.4% |
| Q4 25 | $-0.10 | $-0.08 | ||
| Q3 25 | $-0.06 | $-0.09 | ||
| Q2 25 | $-0.30 | $-0.09 | ||
| Q1 25 | $-0.18 | $-0.08 | ||
| Q4 24 | $-0.40 | $-0.07 | ||
| Q3 24 | $-0.18 | $-0.10 | ||
| Q2 24 | $-0.43 | $-0.09 | ||
| Q1 24 | — | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $319.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $48.6M | $246.9M |
| Total Assets | $63.4M | $343.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $319.8M | ||
| Q3 25 | — | $297.3M | ||
| Q2 25 | — | $312.8M | ||
| Q1 25 | — | $116.6M | ||
| Q4 24 | — | $139.0M | ||
| Q3 24 | $613.6K | $157.7M | ||
| Q2 24 | — | $172.7M | ||
| Q1 24 | — | $124.0M |
| Q4 25 | $48.6M | $246.9M | ||
| Q3 25 | $49.5M | $219.0M | ||
| Q2 25 | $4.7M | $248.7M | ||
| Q1 25 | $5.2M | $55.1M | ||
| Q4 24 | $2.3M | $71.5M | ||
| Q3 24 | $2.5M | $88.8M | ||
| Q2 24 | $2.9M | $108.9M | ||
| Q1 24 | — | $53.8M |
| Q4 25 | $63.4M | $343.3M | ||
| Q3 25 | $69.8M | $316.6M | ||
| Q2 25 | $31.1M | $333.3M | ||
| Q1 25 | $34.1M | $138.4M | ||
| Q4 24 | $35.0M | $160.4M | ||
| Q3 24 | $22.0M | $180.2M | ||
| Q2 24 | $21.2M | $200.4M | ||
| Q1 24 | — | $153.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.7M | $-26.7M |
| Free Cash FlowOCF − Capex | $-18.6M | — |
| FCF MarginFCF / Revenue | -196.3% | — |
| Capex IntensityCapex / Revenue | 167.6% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-37.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.7M | $-26.7M | ||
| Q3 25 | $-3.2M | $-24.2M | ||
| Q2 25 | $-3.2M | $-20.2M | ||
| Q1 25 | $-4.7M | $-22.0M | ||
| Q4 24 | $2.7M | $-18.3M | ||
| Q3 24 | $-2.3M | $-21.6M | ||
| Q2 24 | $-1.9M | $-21.5M | ||
| Q1 24 | — | $-19.8M |
| Q4 25 | $-18.6M | — | ||
| Q3 25 | $-9.6M | $-24.3M | ||
| Q2 25 | $-4.0M | — | ||
| Q1 25 | $-5.2M | — | ||
| Q4 24 | $2.4M | $-18.3M | ||
| Q3 24 | $-2.9M | $-21.6M | ||
| Q2 24 | $-2.8M | $-21.7M | ||
| Q1 24 | — | $-19.9M |
| Q4 25 | -196.3% | — | ||
| Q3 25 | -139.7% | — | ||
| Q2 25 | -69.6% | — | ||
| Q1 25 | -105.9% | — | ||
| Q4 24 | 166.2% | -905.5% | ||
| Q3 24 | -90.2% | -1210.9% | ||
| Q2 24 | -184.3% | -1951.9% | ||
| Q1 24 | — | -584.5% |
| Q4 25 | 167.6% | — | ||
| Q3 25 | 93.8% | — | ||
| Q2 25 | 13.8% | — | ||
| Q1 25 | 11.6% | — | ||
| Q4 24 | 19.5% | 0.1% | ||
| Q3 24 | 20.5% | 2.0% | ||
| Q2 24 | 58.0% | 18.1% | ||
| Q1 24 | — | 4.1% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DUOT
| Services And Consulting Related Parties | $8.5M | 90% |
| Other | $929.3K | 10% |
TSHA
Segment breakdown not available.
